Can COVID-19 pandemic surveillance reduce nosocomial urinary infections in urologic surgery?


Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 17 7 2023
pubmed: 26 5 2023
entrez: 26 5 2023
Statut: ppublish

Résumé

Since COVID-19 pandemic spread, strict preventive measures were adopted to reduce the risk of transmission. Antiseptic dispensers for hand hygiene were diffusely available for patients and hospital staff. To investigate the prophylactic role played by the strict antiseptic rules adopted during pandemic, the rates of nosocomial urinary infections in 2019 and 2020 were compared. Patients' clinical pre-operative characteristics, symptoms, fever, and laboratory data were recorded pre- and post-operatively. Urological surgery was classified in five categories: 1. major surgery 2. upper urinary tract endoscopy, 3. lower urinary tract endoscopy, 4. minor surgery, and 5. Nephrostomy and ureteral stenting. Clavien-Dindo complication score was used. Statistical analysis was performed with R 3.4.2 software. Out of 495 patients, 383 (57.1%) underwent surgical intervention in pre-pandemic March-May 2019 period and 212 (42.9%) in the same pandemic 2020 interval. Preoperatively, 40 (14.1%) and 11 (5.2%) and 77 (27.3%) and 37 (17.5%) patients had fever ( Preoperative and post-operative clinical and laboratory signs of nosocomial urinary infection showed a statistically significant lower incidence during the pandemic period in 2020. This observation could be ascribed to the strong preventive measures, to the medical staff high adherence to hygiene and the diffuse availability of hand sanitizers.

Identifiants

pubmed: 37232522
doi: 10.1177/03915603231175721
pmc: PMC10225790
doi:

Substances chimiques

Anti-Infective Agents, Local 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-552

Auteurs

Vincenzo Serretta (V)

Candela Clinic, Urology Unit, Palermo, Italy.

Piero Mannone (P)

Department Surgical, Oncological and Oral Sciences, Urology Unit University of Palermo, Palermo, Italy.

Davide Baiamonte (D)

Department Surgical, Oncological and Oral Sciences, Urology Unit University of Palermo, Palermo, Italy.

Angelo Armenio (A)

Candela Clinic, Urology Unit, Palermo, Italy.

Marcello Lamartina (M)

Candela Clinic, Urology Unit, Palermo, Italy.

Giuseppe Scalici (G)

Candela Clinic, Urology Unit, Palermo, Italy.

Alchiede Simonato (A)

Department Surgical, Oncological and Oral Sciences, Urology Unit University of Palermo, Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH